RxDoctor Payments Data

Seemant Chaturvedi, MD

Neurology · Baltimore, MDNPI 1154369882

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,965 of the $25,017 with a category attached, or 87.8%. 11 manufacturers reported payments, led by Bayer at 51.0% of the total. 2025 is the largest year on record at $18,634, more than ten times the $147 reported in 2019.

$25,017in general payments, 2019–2025

Across 42 payments — averaging $595.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$13K
  • Novartis$10K
  • AstraZeneca$716
  • Janssen Scientific Affairs, LLC$391
  • Philips North America LLC$378
  • BTG International Inc.$210
  • plus $258 from 5 others
$154,921in research payments, 2019–2025

Across 3 payments — averaging $51,640 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$155K

What the payments were for

  • Consulting fees$21,96588%
  • Travel & lodging$1,2785%
  • Food & beverage$1,7747%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,017 in reported general payments places this provider in the 85th percentile of 442 neurology providers in Maryland.

See all neurology providers in Maryland

Medicare billing

Part B allowed, 2024
$23,268
Medicare patients
110
Services billed
223

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →